Thermo Fisher Co-Marketing Premier Biosoft's Glycan Analysis Software | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said it has signed an agreement to co-market Premier Biosoft's SimGlycan software for analyzing glycan-based data.

The deal is expected to further glycobiology by quickening the characterization of complex glycans through automated interpretation of data generated by Thermo Fisher's mass spectrometers, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.